SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-19-316290
Filing Date
2019-12-17
Accepted
2019-12-17 16:43:35
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d834100d424b5.htm 424B5 429426
2 GRAPHIC g834100g11s30.jpg GRAPHIC 49887
3 GRAPHIC g834100g26d14.jpg GRAPHIC 28142
  Complete submission text file 0001193125-19-316290.txt   538385
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-223584 | Film No.: 191290259
SIC: 2834 Pharmaceutical Preparations